The National Cancer Data Base report on ovarian cancer treatment in United States hospitals

Cancer

Volumn 78, Issue 10, 1996, Pages 2236-2246

  Partridge, Edward E ^a   Phillips, Jerri Linn ^b   Menck, Herman R ^b  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b AMERICAN COLLEGE OF SURGEONS   (United States)

Author keywords

cancer treatment; National Cancer Data Base; ovarian cancer; survival

Indexed keywords

ANTINEOPLASTIC AGENT;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; DATA BASE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; OVARY CANCER; PRIORITY JOURNAL; TREATMENT OUTCOME; UNITED STATES;

ADULT; AGED; AGED, 80 AND OVER; DATA COLLECTION; DATABASES, FACTUAL; FEMALE; HUMANS; MALE; MIDDLE AGED; OVARIAN NEOPLASMS; SURVIVAL RATE; UNITED STATES;

EID: 0030002745     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19961115)78:10<2236::AID-CNCR28>3.0.CO;2-Z     Document Type: Article

References (17)

1. Parker SL, Tong T, Bolden S, Wingo PA. Cancer statistics, 1996. CA Cancer J Clin 1996;46(1):5-27.
2. Berek JK, Hacker NF. Practical gynecologic oncology. 2nd ed. Baltimore: William & Wilkins, 1994.
3. Jacobs I, Bridges J, Reynolds C, Stabile I, Kemsley P, Grudzinskas J, et al. Multimodal approach to screening for ovarian cancer. Lancet 1988;2:268-71.
4. Ovarian cancer: screening, treatment, and followup. NIH Consensus Statement 1994, April 5-7. 1994;12(3):1-30.
5. McQuire WP, Hoskiss WJ, Brady MF, Kucera PR, Partridge EE, Look KY, et al. Cyclophosphamide and cisplatin compared with paclitaxel and cisplatin in patients with stage III and stage IV ovarian cancer. N Engl J Med 1996;334:1-63.
6. American College of Surgeons Commission on Cancer. Cancer program standards. Standards of the Commission on Cancer, vol. 1. Chicago: American College of Surgeons, 1996.
7. American College of Surgeons Commission on Cancer. Data acquisition manual. Revised ed. Chicago: American College of Surgeons, Chicago, 1994.
8. Gordon B, editor. Data exchange standards and record description, version 3.0. Standards for cancer registries. vol. 1. Sacramento: North American Association of Central Cancer Registries, 1994.
9. Averette HE, Jancek, MF, Menck HR. The national cancer data base report on ovarian cancer. Cancer 1995;1096-103.
10. Kosary CL, Ries LAG, Hankey BF, Miller BA, Harras A, Devessa SS, et al, editors. SEER cancer statistics review: 1973-1992 Tables and graphs. NIH publication no. 95-2789. Bethesda: National Cancer Institute, 1995.
11. U.S. Bureau of the Census. Statistical abstract of the United States: 1995. 115th ed. Washington, DC: U.S. Department of Commerce, Bureau of the Census, 1995.
12. Sobin LH, Thomas LB, Percy C, Henson DE. A coded compendium of the international histological classification of tumours. Geneva: World Health Organization, 1978.
13. Berg JW. Morphologic classification of human cancer. In: Schottenfeld D, Fraumeni JF, editors. Cancer epidemiology and prevention. Philadelphia: WB Saunders, 1982.
14. Percy C, VanHolten V, Muir C, editors. International classification of diseases for oncology. 2nd ed. Geneva: World Health Organization, 1990.
15. Beahrs OH, Henson DE, Hutter RVP, Kennedy BJ, editors. Manual for staging of cancer. 4th ed. Philadelphia: JB Lippincott, 1992.
16. Averette HE, Hoskins W, Nguyen HN, Boike G, Flessa HC, Chmiel JS, et al. National survey of ovarian cancer. Cancer 1993; Feb (suppl):1629-38.
17. Shambaugh E, Young JL Jr., Zippin C, Lum D, Akers C, Weiss MA. Statistics and epidemiology for cancer registrars. Self-instructional manual for cancer registrars, book 7. Bethesda: National Institutes of Health, 1995.